ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974